Goldtent TA Paradise

“CONCLUSION

Mass treatments with IVM most likely caused the 14-fold reduction in excess deaths in Peru through December 1, 2020, prior to a 13-fold increase afterIVM policywas reversed. The appropriate clinical follow-up to IVM treatmentsfor COVID-19in the 25 states of Peru, with a combinedtotal population of 33million,is more nationaldeploymentsof IVM treatments interim and complementary to immunizations. Since a likely biological mechanismof IVM against SARS-CoV-2 is non-epitope specificcompetitive binding to viral spike protein,theefficacy of IVM may wellprove to be conserved against emerging viral mutant strains.64Given thatforthe ten MOTstates of Peru, mean 74% reductions in mortality were accrued over just 30 days, rapid confirmation would be obtainable for success ofsuch national IVM deployments.”